NxTheraNxThera
N

NxThera

Developer of minimally invasive thermal water vapor therapy for treating benign prostatic hyperplasia (BPH).

2008Active53158

About

NxThera developed the Rezūm System, a medical device that uses convective water vapor energy to treat benign prostatic hyperplasia (BPH) in a minimally invasive, office-based procedure. The company focused on improving patient quality of life by providing an alternative to traditional surgery or long-term medication for prostate conditions.

Technology stack

detected 2026-06-18
Est. monthly stack spend~$1,460/mo
EmailMicrosoft 365
Stack
jQueryBootstrap
Analytics
Google Tag Manager
Video
Vimeo
Cookie consent
OneTrust
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does NxThera do?

NxThera developed the Rezūm System, a medical device that uses convective water vapor energy to treat benign prostatic hyperplasia (BPH) in a minimally invasive, office-based procedure. The company focused on improving patient quality of life by providing an alternative to traditional surgery or long-term medication for prostate conditions.

How much funding has NxThera raised?

NxThera has raised a total of $3M in funding. The most recent round on record is Series A.

Where is NxThera headquartered?

NxThera is headquartered in Maple Grove, United States.

When was NxThera founded?

NxThera was founded in 2008.

What industry does NxThera operate in?

NxThera operates in Medical Devices, Urology, HealthTech.

How many employees does NxThera have?

NxThera has approximately 53158 people on record.